Breckenridge Pharmaceuticals, Metabolite Labs, and Pamlab filed suit against Macoven Pharmaceuticals over a patent related to compositions for preventing or reducing elevated metabolic levels.  12/9, Southern District of New York, 1:2011cv09022.